This study is currently not recruiting participants.

Treatment Use of Oral MKC-1 in a Single Patient: Expansion of MKC-102

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The objective of this study is to provide continued access to oral MKC-1 in a cancer patient who is currently participating in and benefiting from treatment under protocol MKC-102 (IRB # 1010002795).

Detailed description of study

The objective of this study is to provide continued access to oral MKC-1 in a cancer patient who is currently participating in and benefiting from treatment under protocol MKC-102 (IRB # 1010002795).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
  • Age: 100 years or below
  • Gender: All
Updated on 31 Jan 2012. Study ID: 1112007594

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team